Tenon Medical (TNON) Stock Price, News & Analysis

Company Overview

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

Key Stats

• Today's Range: $0.90 to $0.95
• 50-Day Range: $0.87 to $1.31
• 52-Week Range: $0.85 to $15.79
• Volume: 224,586 shs
• Average Volume: 2.51 million shs
• Market Capitalization: $6.86 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.67
• Consensus Rating: Buy

Tenon Medical Stock Analysis - MarketRank™

Tenon Medical scored higher than 44% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Tenon Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Tenon Medical has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Tenon Medical is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Tenon Medical is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Tenon Medical has a P/B Ratio of 1.27. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.23% of the float of Tenon Medical has been sold short.

Short Interest Ratio / Days to Cover

Tenon Medical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tenon Medical has recently decreased by 90.31%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Tenon Medical does not currently pay a dividend.

Dividend Growth

Tenon Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.23% of the float of Tenon Medical has been sold short.

Short Interest Ratio / Days to Cover

Tenon Medical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tenon Medical has recently decreased by 90.31%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Tenon Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 4.70% of the stock of Tenon Medical is held by insiders.

Percentage Held by Institutions

Only 22.74% of the stock of Tenon Medical is held by institutions.

TNON Stock Analysis - Frequently Asked Questions

How have TNON shares performed this year?

Tenon Medical's stock was trading at $1.88 at the beginning of 2025. Since then, TNON shares have decreased by 51.9% and is now trading at $0.9035.
View the best growth stocks for 2025 here.

How were Tenon Medical's earnings last quarter?

Tenon Medical, Inc. (NASDAQ:TNON) announced its quarterly earnings results on Tuesday, May, 13th. The company reported ($1.01) EPS for the quarter, beating analysts' consensus estimates of ($1.06) by $0.05. The firm earned $0.73 million during the quarter, compared to analysts' expectations of $0.76 million. Tenon Medical had a negative net margin of 417.57% and a negative trailing twelve-month return on equity of 558.92%.
Read the conference call transcript.

When did Tenon Medical IPO?

Tenon Medical (TNON) raised $16 million in an initial public offering on Wednesday, April 27th 2022. The company issued 3,200,000 shares at $4.50-$5.50 per share.

Who are Tenon Medical's major shareholders?

Tenon Medical's top institutional investors include Jane Street Group LLC (0.23%). Insiders that own company stock include Dick Steven M Van, Richard Ginn and Steven M Foster.
View institutional ownership trends.

How do I buy shares of Tenon Medical?

Shares of TNON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Tenon Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tenon Medical investors own include Ardelyx (ARDX), Broadcom (AVGO), CrowdStrike (CRWD), First Financial Bankshares (FFIN), Eli Lilly and Company (LLY) and Meta Platforms (META).

Company Calendar

• Last Earnings: 5/13/2025
• Today: 6/21/2025
• Next Earnings (Estimated): 8/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:TNON
• CIK: 1560293
• Web: www.tenonmed.com
• Phone: 408-649-5760
• Fax: N/A
• Employees: 8
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $4.67
• High Stock Price Target: $8.00
• Low Stock Price Target: $3.00
• Potential Upside/Downside: +416.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($27.23)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$13.67 million
• Net Margins: -417.57%
• Pretax Margin: -417.57%
• Return on Equity: -558.92%
• Return on Assets: -129.73%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.46
• Quick Ratio: 5.19

Sales & Book Value

• Annual Sales: $3.28 million
• Price / Sales: 2.09
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.71 per share
• Price / Book: 1.27

Miscellaneous

• Outstanding Shares: 7,590,000
• Free Float: 7,233,000
• Market Cap: $6.86 million
• Optionable: Not Optionable
• Beta: 1.23